Previous 10 | Next 10 |
A look at the top 10 most actives in the United States Faraday Future Intelligent Electric Inc. (FFIE) rose 37.2% to $0.7466 on volume of 94,759,512 shares GameStop Corporation (GME) rose 0.0% to $46.5702 on volume of 64,189,668 shares Trinity Place Holdings Inc. (TPHS) rose 126.9% to $0....
2024-06-07 09:00:40 ET More on related stocks: Roaring Kitty Sparks GameStop Surge With $100M Bet: Analysis And Insights GameStop Stock: Disconnected From Fundamentals GameStop: 'Roaring Kitty' Is Back, Nearly All-In With $175 Million Bet Lyft attracts analys...
2024-06-06 22:31:45 ET More on Geron Geron Corporation: A High-Risk Deal With A Good Chance Of Success Geron Corporation (GERN) Q1 2024 Earnings Call Transcript Geron: FDA PDUFA Review With Continued Imetelstat Advancement Geron GAAP EPS of -$0.09 beats by $0...
Approval across ESA ineligible and ESA relapsed/refractory patients with LR-MDS with transfusion-dependent anemia, regardless of ring sideroblast (RS) status Durable and sustained red blood cell transfusion independence, increases in hemoglobin levels and reduction in transfusion burden o...
2024-05-23 17:49:01 ET Summary Geron Corporation's unique product, Imetelstat, could potentially bring real benefits to hematological diseases with a Total Addressable Market value of $7 billion by 2031. Clinical studies have shown statistical evidence supporting the effectiveness...
2024-05-03 00:30:12 ET Image source: The Motley Fool. Geron (NASDAQ: GERN) Q1 2024 Earnings Call May 02, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Geron (GERN) Q1 2024 Earnings Call Transcript
2024-05-02 12:32:10 ET Geron Corporation (GERN) Q1 2024 Earnings Conference Call May 2, 2024 8:00 am ET Corporate Participants Aron Feingold - VP of IR and Corporate Communications John Scarlett - Chairman, President and Chief Executive Officer Faye Feller - Exec...
2024-05-02 07:08:56 ET More on Geron Geron: FDA PDUFA Review With Continued Imetelstat Advancement Considering The Merits Of A Gamble On Geron Corporation Geron: Advisory Nod Boosts Approval Odds, But Market Position Remains Hazy Geron Q1 2024 Earnings Previe...
Resideo Technologies Inc. (REZI) is expected to report $0.33 for Q1 2024 Schneider National Inc. (SNDR) is expected to report $0.13 for Q1 2024 Murphy Oil Corporation (MUR) is expected to report $0.82 for Q1 2024 Astronics Corp. - Class B (ATROB) is expected to report for Q1 2024 ...
June 16, 2024 PDUFA date for imetelstat NDA for the treatment of transfusion-dependent anemia in adult patients with lower-risk MDS Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelsta...
News, Short Squeeze, Breakout and More Instantly...
2024-06-10 14:00:11 ET Corinne Jenkins from Goldman Sachs issued a price target of $6.00 for GERN on 2024-06-10 11:59:00. The adjusted price target was set to $6.00. At the time of the announcement, GERN was trading at $4.945. The overall price target consensus is at $5....